What is Hyphens Pharma International Pre-Tax Income?
Pretax income is the income that a company earns before paying income taxes. Hyphens Pharma International's pretax income for the
six
months ended in Dec. 2024 was S$5.5 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was S$13.0 Mil.
Hyphens Pharma International's pretax margin was 5.74%.
During the past 10 years, Hyphens Pharma International's highest Pretax Margin was 8.80%. The lowest was 5.43%. And the median was 6.46%.
Hyphens Pharma International Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hyphens Pharma International's Pre-Tax Income
For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyphens Pharma International's Pre-Tax Income Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Hyphens Pharma International's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$13.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hyphens Pharma International (SGX:1J5) Pre-Tax Income Explanation
Hyphens Pharma International's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 10 years, Hyphens Pharma International's highest Pretax Margin was 8.80%. The lowest was 5.43%. And the median was 6.46%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hyphens Pharma International Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Hyphens Pharma International's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment; and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGX:1J5 has been successfully added to your 